Instructions to Authors

The Journal of Turkish Spinal Surgery (www.jtss.org), is the official publication of the Turkish Spinal Society. It is a double-blind peer-reviewed multidisciplinary journal for the physicians who deal with spinal diseases and publishes original studies which offer significant contributions to the development of the spinal knowledge. The journal publis¬hes original scientific research articles, invited reviews and case reports that are accepted by the Editorial Board, in English.

The journal is published once in every three months and a vo¬lume consists of four issues.

The Journal of Turkish Spinal Surgery is published four ti¬mes a year: on January, April, July, and October.

PEER REVIEW

Article is reviewed by secretaries of the journal after it is uploaded to the web site. Article type, presence of the all sections, suitability according to the number of words, name of the authors with their institutions, corresponding address, mail addresses, telephone numbers and ORCID numbers are all evaluated and shortcomings are reported to the editor. Editor request the all defect from the authors and send to vice editors and native English speaker editor after completion of the article. Vice editors edit the blinded article and this blinded copy is sent to two referees. After reviewing of the article by the referees in maximum one month, the review report evaluating all section and his decision is requested, and this blinded report is sent to the author. In fifteen days, revision of the article is requested from the authors with the appreciate explanation. Revised blinded copy is sent to the referees for the new evaluation. Editor if needed may sent the manuscript to a third referee. Editorial Board has the right to accept, revise or reject a manuscript.

-Following types of manuscripts related to the field of “Spinal Surgery” with English Abstract and Keywords are accepted for publication: I- Original clinical and experimental research studies; II- Case presentations; and III- Reviews.

AUTHOR’S RESPONSIBILITY

The manuscript submitted to the journal should not be previously published (except as an abstract or a preli¬minary report) or should not be under consideration for publication elsewhere. Every person listed as an author is expected to have been participated in the study to a sig¬nificant extent. All authors should confirm that they have read the study and agreed to the submission to the Jour¬nal of Turkish Spinal Surgery for publication. This should be notified with a separate document as shown in the “Co¬ver Letter” in the appendix. Although the editors and refe¬rees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. The sour¬ce of any financial support for the study should be clearly indicated in the Cover Letter.

lt is the author’s responsibility to ensure that a patient‘s anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed upon the informed con¬sent of the patients and in accordance with all guidelines for experimental investigation on human subjects app¬licable at the institution(s) of all authors.

Authors should mask patients’ eyes and remove patients’ names from figu¬res unless they obtain written consent to do so from the patients; and this consent should be submitted along with the manuscript.

CONFLICTS OF INTEREST

Authors must state all possible conflicts of interest in the manuscript, including financial, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding”.

ARTICLE WRITING

Clinically relevant scientific advances during recent years include use of contemporary outcome measures, more sophisticated statistical approaches, and increasing use and reporting of well-formulated research plans (particu¬larly in clinical research).

Scientific writing, no less than any other form of writing, reflects a demanding creative process, not merely an act: the process of writing changes thought. The quality of a report depends on the quality of thought in the design and the rigor of conduct of the research. Well-posed ques¬tions or hypotheses interrelate with the design. Well-posed hypotheses imply design and design implies the hypot¬heses. The effectiveness of a report relates to brevity and focus. Drawing the attention to a few points will allow aut¬hors to focus on critical issues. Brevity is achieved in part by avoiding repetition (with a few exceptions to be noted), clear style, and proper grammar. Few original scientific ar¬ticles need to be longer than 3000 words. Longer articles may be accepted if substantially novel methods are re¬ported, or if the article reflects a comprehensive review of the literature.

Although authors should avoid redundancy, effectively communicating critical information often requ¬ires repetition of the questions (or hypotheses/key issues) and answers. The questions should appear in the Abstract, Introduction, and Discussion, and the answers should ap¬pear in the Abstract, Results, and Discussion sections.

Although most journals publish guidelines for formatting a manuscript and many have more or less established wri¬ting styles (e.g., the American Medical Association Manual of Style), styles of writing are as numerous as authors. The Journal of Turkish Spinal Surgery traditionally has used the AMA style as a general guideline. However, few scientific and medical authors have the time to learn these styles. Therefore, within the limits of proper grammar and clear, effective communication, we will allow individual styles.

Permissions: As shown in the example in the appendix (Letter of Copyright Transfer) the authors should decla¬re in a separate statement that the study has not been previously published and is not under consideration for publication elsewhere. Also, the authors should state in the same statement that they transfer copyrights of their manuscript to our Journal. Quoted material and borrowed illustrations: if the authors have used any material that had appeared in a copyrighted publication, they are expected to obtain written permission letter and it should be sub¬mitted along with the manuscript.

Review articles: The format for reviews substantially dif¬fers from those reporting original data. However, many of the principles noted above apply. A review still requires an Abstract, an Introduction, and a Discussion. The Intro¬duction still requires focused issues and a rationale for the study. Authors should convey to readers the unique as¬pects of their reviews which distinguish them from other available material (e.g., monographs, book chapters). The main subject should be emphasized in the final paragraph of the Introduction. As for an original research article, the Introduction section of a review typically need not to be longer than four paragraphs. Longer Introductions tend to lose focus, so that the reader may not be sure what novel information will be presented. The sections after the Intro¬duction are almost always unique to the particular review, but need to be organized in a coherent fashion. Headings (and subheadings when appropriate) should follow paral¬lel construction and reflect analogous topics (e.g., diag¬nostic categories, alternative methods, alternative surgical interventions). If the reader considers only the headings, the logic of the review (as reflected in the Introduction) should be clear. Discussion synthesizes the reviewed lite¬rature as a whole coherently and within the context of the novel issues stated in the Introduction.

The limitations should reflect those of the literature, howe¬ver, rather than a given study. Those limitations will relate to gaps in the literature which preclude more or less de¬finitive assessment of diagnosis or selection of treatment, for example. Controversies in the literature should be bri¬efly explored. Only by exploring limitations will the reader appropriately place the literature in perspective. Authors should end the Discussion by abstract statements similar to those which will appear at the end of the Abstract in abbreviated form.

In general, a review requires a more extensive literature review than an original research article, although this will depend on the topic. Some topics (e.g., osteoporosis) co¬uld not be comprehensively referenced, even in an entire monograph. However, authors need to ensure that a revi¬ew is representative of the entire body of literature, and when that body is large, many references are required.

Original Articles: - Original articles should contain the following sections: “Title Page”, “Abstract”, “Keywords”, “Introduction”, “Materi¬als and Methods”, “Results”, “Discussion”, “Conclusions”, and “References”. “Keywords” sections should also be added if the original article is in English.

- Title (80 characters, including spaces): Just as the Abstract is important in capturing a reader’s attention, so is the tit¬le. Titles rising or answering questions in a few brief words will far more likely do this than titles merely pointing to the topic. Furthermore, such titles as “Bisphosponates re¬duce bone loss” effectively convey the main message and readers will more likely remember them. Manuscripts that do not follow the protocol described here will be returned to the corresponding author for technical revision before undergoing peer review. All manuscripts in English, should be typed double-spaced on one side of a standard typewriter paper, leaving at least 2.5 cm. mar¬gin on all sides. All pages should be numbered beginning from the title page.

- Title page should include: a) informative title of the paper, b) complete names of each author with their institutional affiliations, c) name, address, fax and telephone number, e-mail of the corresponding author, d) address for the rep¬rints if different from that of the corresponding author, e) ORCID numbers of the authors. It should also be stated in the title page that informed con¬sent was obtained from patients and that the study was approved by the ethics committee.

The “Level of Evidence” should certainly be indicated in the title page (see Table-1 in the appendix). Also, the field of study should be pointed out as outlined in Table-2 (maximum three fields).

- Abstract: A150 to 250 word abstract should be inclu¬ded at the second page. The abstract should be written in English and for all articles. The main topics to be included in Abstract sec¬tion are as follows: Background Data, Purpose, Materials- Methods, Results and Conclusion. The Abstract should be identical in meaning. Generally, an Abstract should be written after the entire manuscript is completed. The reason relates to how the process of writing changes thought and perhaps even purpose. Only after careful consideration of the data and a synthesis of the literature can author(s) write an effective abstract. Many readers now access medical and scientific information via Web-based databases rather than brow¬sing hard copy material. Since the reader’s introduction occurs through titles and abstracts, substantive titles and abstracts more effectively capture a reader’s attention regardless of the method of access. Whether reader will examine an entire article often will depend on an abstract with compelling information. A compelling Abstract con¬tains the questions or purposes, the methods, the results (most often quantitative data), and the conclusions. Each of these may be conveyed in one or two statements. Com¬ments such as “this report describes...” convey little useful information.

-Key Words : Standard wording used in scientific indexes and search engines should be preferred. The minimum number for keywords is three and the maximum is five.

- Introduction (250 – 750 words): It should contain infor¬mation on historical literature data on the relevant issue; the problem should be defined; and the objective of the study along with the problem solving methods should be mentioned.

Most studies, however, are published to: (1) report entirely novel findings (frequently case reports, but sometimes substantive basic or clinical studies); (2) confirm previously reported work (eg, case reports, small preliminary series) when such confirmation remains questionable; and (3) introduce or address cont¬roversies in the literature when data and/or conclusions conflict. Apart from reviews and other special articles, one of these three purposes generally should be apparent (and often explicit) in the Introduction.

The first paragraph should introduce the general topic or problem and emphasized its importance, a second and perhaps a third paragraph should provide the rationale of the study, and a final paragraph should state the questi¬ons, hypotheses, or purposes.

One may think of formulating rationale and hypotheses as Aristotelian logic (a modal syllogism) taking the form: If A, B, and C, then D, E, or F. The premises A, B, and C, reflect ac¬cepted facts whereas D, E, or F reflect logical outcomes or predictions. The premises best come from published data, but when data are not available, published observations (typically qualitative), logical arguments or consensus of opinion can be used. The strength of these premises is ro¬ughly in descending order from data to observations or ar¬gument to opinion. D, E, or F reflects logical consequences. For any set of observations, any number of explanations (D, E, or F) logically follows. Therefore, when formulating hypotheses (explanations), researchers designing expe¬riments and reporting results should not rely on a single explanation.

With the rare exception of truly novel material, when es¬tablishing rationale authors should generously reference representative (although not necessarily exhaustive) li¬terature. This rationale establishes novelty and validity of the questions and places it within the body of literature. Writers should merely state the premises with relevant ci¬tations (superscripted) and avoid describing cited works and authors` names. The exceptions to this approach include a description of past methods when essential to developing rationale for a new method, or a mention of authors` names when important to establish historic pre¬cedent. Amplification of the citations may follow in the Discussion when appropriate. In establishing a rationale, new interventions of any sort are intended to solve certain problems. For example, new implants (unless conceptu¬ally novel) typically will be designed according to certain criteria to eliminate problems with previous implants. If the purpose is to report a new treatment, the premises of the study should include those explicitly stated problems (with quantitative frequencies when possible) and they should be referenced generously.

The final paragraph logically flows from the earlier ones, and should explicitly state the questions or hypotheses to be addressed in terms of the study (independent, de¬pendent) variables. Any issue not posed in terms of study variables cannot be addressed meaningfully. Focus of the report relates to focus of these questions, and the report should avoid questions for which answers are well descri¬bed in the literature (e.g., dislocation rates for an implant designed to minimize stress shielding). Only if there are new and unexpected information should data reported apart from that essential to answer the stated questions.

- Materials - Methods (1000-1500 words): Epidemiologi¬cal/ demographic data regarding the study subjects; clini¬cal and radiological investigations; surgical technique app¬lied; evaluation methods; and statistical analyses should be described in detail.

In principle, the Materials and Methods should contain adequate detail for another investigator to replicate the study. In practice, such detail is neither practical nor de¬sirable because many methods will have been published previously (and in greater detail), and because long desc¬riptions make reading difficult. Nonetheless, the Materials and Methods section typically will be the longest section. When reporting clinical studies authors must state appro¬val of the institutional review board or ethics committees according to the laws and regulations of their countries. Informed consent must be stated where appropriate. Such approval should be stated in the first paragraph of Materi¬als and Methods. At the outset the reader should grasp the basic study design. Authors should only briefly escribe and reference previously reported methods. When authors modify those methods, the modifications require additio¬nal description.

In clinical studies, the patient population and demograp¬hics should be outlined at the outset. Clinical reports must state inclusion and exclusion criteria and whether the seri¬es is consecutive or selected; if selected, criteria for selec¬tion should be stated. The reader should understand from this description all potential sources of bias such as refer¬ral, diagnosis, exclusion, recall, or treatment bias. Given the expense and effort for substantial prospective studies, it is not surprising that most published clinical studies are ret¬rospective.

Such studies often are criticized unfairly for being ret¬rospective, but that does not negate the validity or va¬lue of a study. Carefully designed retrospective studies provide most of the information available to clinicians. However, authors should describe potential problems such as loss to follow-up, difficulty in matching, missing data, and the various forms of bias more common with retros¬pective studies.

If authors use statistical analysis, a paragraph should ap¬pear at the end of Materials and Methods stating all sta¬tistical tests used. When multiple tests are used, authors should state which tests are used for which sets of data. All statistical tests are associated with assumptions, and when it is not obvious the data would meet those assump¬tions, the authors either should provide the supporting data (e.g., data are normally distributed, variances in gro-ups are similar) or use alternative tests. Choice of level of significance should be justified. Although it is common to choose a level of alpha of 0.05 and a beta of 0.80, these levels are somewhat arbitrary and not always appropria¬te. In the case where the implications of an error are very serious (e.g., missing the diagnosis of a cancer), different alpha and beta levels might be chosen in the study design to assess clinical or biological significance.

- Results (250-750 words): “Results” section should be written in an explicit manner, and the details should be described in the tables. The results section can be divided into sub-sections for a more clear understanding.

If the questions or issues are adequately focused in the Introduction section, the Results section needs not to be long. Generally, one may need a paragraph or two to persuade the reader of the validity of the methods, one paragraph addressing each explicitly raised question or hypothesis, and finally, any paragraphs to report new and unexpected findings. The first (topic) sentence of each paragraph should state the point or answer the question. When the reader considers only the first sentence in each paragraph in Results, the logic of the authors` interpreta¬tions should be clear. Parenthetic reference to all figures and tables forces the author to textually state the interp¬retation of the data; the important material is the authors` interpretation of the data, not the data.

Statistical reporting of data deserves special consideration. Stating some outcome is increased or decreased(or gre¬ater or lesser) and parenthetically stating the p (or other statistical) value immediately after the comparative terms more effectively conveys information than stating somet¬hing is or is not statistically significantly different from so-mething else (different in what way? the readermay ask). Additionally, avoiding the terms ‘statistically different’ or ‘significantly different’ lets the reader determine whether they will consider the statistical value biologically or clini¬cally significant, regardless of statistical significance.

Although a matter of philosophy and style, actual p valu¬es convey more information than stating a value less than some preset level. Furthermore, as Motulsky notes, “When you read that a result is not significant, don’t stop thinking... First, look at the confidence interval... Second, ask about the power of the study to find a significant dif¬ference if it were there.” This approach will give the reader a much greater sense of biological or clinical significance.

- Discussion (750 - 1250 words): The Discussion section should contain specific elements: a restatement of the problem or question, an exploration of limitations and as-sumptions, a comparison and/or contrast with information (data, opinion) in the literature, and a synthesis of the com¬parison and the author’s new data to arrive at conclusions. The restatement of the problem or questions should only be a brief emphasis. Exploration of assumptions and limi¬tations are preferred to be next rather than at the end of the manuscript, because interpretation of what will follow depends on these limitations. Failure to explore limitations suggests the author(s) either do not know or choose to ig¬nore them, potentially misleading the reader. Exploration of these limitations should be brief, but all critical issues must be discussed, and the reader should be persuaded they do not jeopardize the conclusions.

Next the authors should compare and/or contrast their data with data reported in the literature. Generally, many of these reports will include those cited as rationale in the Introduction. Because of the peculiarities of a given study the data or observations might not be strictly comparable to that in the literature, it is unusual that the literature (inc¬luding that cited in the Introduction as rationale) would not contain at least trends. Quantitative comparisons most effectively persuade the reader that the data in the study are “in the ballpark,” and tables or figures efficiently con¬vey that information. Discrepancies should be stated and explained when possible; when an explanation of a discre¬pancy is not clear that also should be stated. Conclusions based solely on data in the paper seldom are warranted because the literature almost always contains previous in¬formation.

Finally, the author(s) should interpret their data in the light of the literature. No critical data should be overlooked, be¬cause contrary data might effectively refute an argument. That is, the final conclusions must be consistent not only with the new data presented, but also that in the literature.

- Conclusion: The conclusions and recommendations by the authors should be described briefly. Sentences conta¬ining personal opinions or hypotheses that are not based on the scientific data obtained from the study should be avoided.

- References: Care must be exercised to include references that are available in indexes. Data based on personal com¬munication should not be included in the reference list. References should be arranged in alphabetical order and be cited within the text; references that are not cited sho¬uld not be included in the reference list. The abstract of the presentations made at Symposia or Congresses should be submitted together with the manuscript. The following listing method should be used.

References should derive primarily from peer-reviewed journals, standard textbooks or monographs, or well-accepted and stable electronic sources. For citations de¬pendent on interpretation of data, authors generally sho¬uld use only high quality peer-reviewed sources. Abstracts and submitted articles should not be used because many in both categories ultimately do not pass peer review.

They should be listed at the end of the paper in alphabeti¬cal order under the first author’s last name and numbered accordingly. If needed, the authors may be asked to provi¬de and send full text of any reference. If the authors refer to an unpublished data, they should state the name and institution of the study, Unpublished papers and personal communications must be cited in the text. For the abb¬reviations of the journal names, the authors can apply to “list of Journals” in Index Medicus or to the address “http:// www.nlm.nih.gov/tsd/serials/lji.html”.

Please note the following examples of journal, boo¬k and other reference styles:

Journal article:

1. Berk H, Akçalı Ö, Kıter E, Alıcı E. Does anterior spinal ins¬trument rotation cause rethrolisthesis of the lower instru¬mented vertebra? J Turk Spinal Surg. 1997; 8 (1): 5-9.

Book chapter:

2. Wedge IH, Kirkaldy-Willis WH, Kinnard P. Lumbar spinal stenosis. Chapter 5. In: Helfet A, Grubel DM (Eds.). Disorders of the Lumbar Spine. JB Lippincott, Philadelphia 1978; pp: 61-68.

Entire book:

3. Paul LW, Juhl IH (Eds.). The Essentials of Roentgen Interpreta¬tion. Second Edition, Harper and Row, New York 1965; pp: 294-311.

Book with volume number:

4. Stauffer ES, Kaufer H, Kling THF. Fractures and dislocati¬ons of the spine. In: Rock-wood CA, Green DP (Eds.). Fractures in Adults. Vol. 2, JB Lippincott, Philadelphia 1984; pp: 987-1092.

Journal article in press:

5. Arslantaş A, Durmaz R, Coşan E, Tel E. Aneurysmal bone cysts of the cervical spine. J Turk Spinal Surg. (In press).

Book in press :

6. Condon RH. Modalities in the treatment of acute and chronic low back pain. In: Finnison BE (Ed.). Low Back Pain. JB Lippincott (In press).

Symposium :

7. Raycroft IF, Curtis BH. Spinal curvature in myelomenin¬gocele: natural history and etiology. Proceedings of the American Academy of Orthopaedic Surgeons Symposium on Myelomeningocele, Hartford, Connecticut, November 1970, CV Mosby, St. Louis 1972; pp: 186- 201.

Papers presented at the meeting:

8. Rhoton AL. Microsurgery of the Arnold-Chiari malforma¬tion with and without hydromyelia in adults. Presented at the Annual Meeting of the American Association of Neuro-logical Surgeons, Miami, Florida, April 7, 1975.

- Tables: They should be numbered consecutively in the text with Arabic numbers. Each table with its number and title should be typed on a separate sheet of paper. Each table must be able to stand alone; all necessary informa¬tion must be contained in the caption and the table itself so that it can be understood independent from the text. Information should be presented explicitly in “Tables” so that the reader can obtain a clear idea about its content. Information presented in “Tables” should not be repeated within the text. If possible, information in “Tables” should contain statistical means, standard deviations, and t and p values for possibility. Abbreviations used in the table sho¬uld be explained as a footnote.

Tables should complement not duplicate material in the text. They compactly present information, which would be difficult to describe in text form. (Material which may be succinctly described in text should rarely be placed in tables or figures.) Clinical studies for example, often con¬tain complementary tables of demographic data, which although important for interpreting the results, are not critical for the questions raised in the paper. Well focused papers contain only one or two tables or figures for every question or hypothesis explicitly posed in the Introduction section. Additional material may be used for unexpected results. Well-constructed tables are self-explanatory and require only a title. Every column contains a header with units when appropriate.

- Figures: All figures should be numbered consecutively throughout the text. Each figure should have a label pas¬ted on its back indicating the number of the figure, an ar¬row to show the top edge of the figure and the name of the first author. Black-and-white illustrations should be in the form of glossy prints (9x13 cm). The letter size on the figure should be large enough to be readable after the fi¬gure is reduced to its actual printing size. Unprofessional typewritten characters are not accepted. Legends to figu¬res should be written on a separate sheet of paper after the references.

The journal accepts color figures for publication if they enhance the article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can re¬quest that the figures be converted to black and white at no charge. For studies submitted by electronic means, the figures should be in jpeg and tiff formats with a resoluti¬on greater than 300 dpi. Figures should be numbered and must be cited in the text.

- Style: For manuscript style, American Medical Associa¬tion Manual of Style (9th edition). Stedman’s Medical Dic¬tionary (27th edition) and Merriam Webster’s Collegiate Dictionary (10th edition) should be used as standard refe¬rences. The drugs and therapeutic agents must be refer¬red by their accepted generic or chemical names, without abbreviations. Code numbers must be used only when a generic name is not yet available. In that case, the chemi¬cal name and a figure giving the chemical structure of the drug should be given. The trade names of drugs should be capitalized and placed in parentheses after the generic na¬mes. To comply with trademark law, the name and location (city and state/country) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript should be included. The metric system must be used to express the units of measure and degrees Celsius to express tem¬peratures, and SI units rather than conventional units sho¬uld be preferred.

The abbreviations should be defined when they first appe¬ar in the text and in each table and figure. If a brand name is cited, the manufacturer’s name and address (city and state/country) must be supplied.

The address, “Council of Biology Editors Style Guide” (Co¬uncil of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) can be consulted for the standard list of abbrevia-tions.

-Acknowledgments: Note any non-financial acknowledg¬ments. Begin with, “The Authors wish to thank…” All forms of sup¬port, including pharmaceutical industry support should also be stated in Acknowledgments section.

Authors are requested to apply and load inc¬luding the last version of their manuscript to the manuscript submission in the official web address (www.jtss.org). The electronic file must be in Word format (Microsoft Word or Corel Word Perfect). Authors can submit their articles for pub¬lication via internet using the guidelines in the following address: www.jtss.org.

- Practical Tips:

  • 1. Read only the first sentence in each paragraph throug¬hout the text to ascertain whether those statements con¬tain all critical material and the logical flow is clear.
  • 2. Avoid in the Abstract comments such as, “... this report describes...” Such statements convey no substantive infor¬mation for the reader.
  • 3. Avoid references and statistical values in the Abstract.
  • 4. Avoid using the names of cited authors except to estab¬lish historical precedent. Instead, indicate the point in the manuscript by providing citation by superscripting.
  • 5. Avoid in the final paragraph of the Introduction purpo¬ses such as, “... we report our data...” Such statements fail to focus the reader’s (and author’s!) attention on the critical issues (and do not mention study variables).
  • 6. Parenthetically refer to tables and figures and avoid sta¬tements in which a table of figure is either subject or ob¬ject of a sentence. Parenthetic reference places interpretation of the information in the table or figure, and not the table or figure.
  • 7. Regularly count words from the Introduction through Discussion.

TABLE-1. LEVELS OF EVIDENCE

LEVEL- I .
  • 1) Randomized, double-blind, controlled trials for which tests of statistical significance have been performed
  • 2) Prospective clinical trials comparing criteria for diagno¬sis, treatment and prognosis with tests of statistical signifi¬cance where compliance rate to study exceeds 80%
  • 3) Prospective clinical trials where tests of statistical igni¬ficance for consecutive subjects are based on predefined criteria and a comparison with universal (gold standard) reference is performed
  • 4) Systematic meta-analyses which compare two or more studies with Level I evidence using pre-defined methods and statistical comparisons.
  • 5) Multi-center, randomized, prospective studies
LEVEL –II.
  • 1) Randomized, prospective studies where compliance rate is less than 80%
  • 2) All Level-I studies with no randomization
  • 3) Randomized retrospective clinical studies
  • 4) Meta-analysis of Level-II studies
LEVEL– III.
  • 1) Level-II studies with no randomization (prospective cli¬nical studies etc.)
  • 2) Clinical studies comparing non-consecutive cases (wit¬hout a consistent reference range)
  • 3) Meta-analysis of Level III studies
LEVEL- IV.
  • 1) Case presentations
  • 2) Case series with weak reference range and with no sta¬tistical tests of significance
LEVEL – V.
  • 1) Expert opinion and review articles
  • 2) Anecdotal reports of personal experience regarding a study, with no scientific basis

TABLE-2. CLINICAL AREAS

Anatomy
  • Morphometric analysis

Anesthesiology

Animal study

Basic Science
  • Biology
  • Biochemistry
  • Biomaterials
  • Bone mechanics
  • Bone regeneration
  • Bone graft
  • Bone graft sustitutes
  • Drugs
Disc
  • Disc Degeneration
  • Herniated Disc
  • Disc Pathology
  • Disc Replacement
  • IDET
Disease/Disorder
  • Congenital
  • Genetics
  • Degenerative disease
  • Destructive (Spinal Tumors)
  • Metabolic bone disease
  • Rheumatologic
Biomechanics Cervical Spine
  • Cervical myelopathy
  • Cervical reconstruction
  • Cervical disc disease
  • Cervical Trauma
  • Degenerative disease
Complications
  • Early
  • Late
  • Postoperative
Deformity
  • Adolescent idiopathic scoliosis
  • Kyphosis
  • Congenital spine
  • Degenerative spine conditions
Diagnostics
  • Radiology
  • MRI
  • CT scan
  • Others

Epidemiology

Etiology

Examination

Experimental study

Fusion
  • Anterior
  • Posterior
  • Combined
  • With instrumentation
Infection of the spine
  • Postoperative
  • Rare infections
  • Spondylitis
  • Spondylodiscitis
  • Tuberculosis

Instrumentation

Meta-Analysis

Osteoporosis

  • Bone density
  • Fractures
  • Kyphoplasty
  • Medical Treatment
  • Surgical Treatment
Outcomes
  • Conservative care
  • Patient Care
  • Primary care
  • Quality of life research
  • Surgical
Pain
  • Chronic pain
  • Discogenic pain
  • Injections
  • Low back pain
  • Management of pain
  • Postoperative pain
  • Pain measurement
Physical Therapy
  • Motion Analysis
  • Manipulation
  • Non-Operative Treatment
Surgery
  • Minimal invasive
  • Others
  • Reconstructive surgery

Thoracic Spine

Thoracolumbar Spine

Lumbar Spine

Lumbosacral Spine

Psychology

Trauma
  • Fractures
  • Dislocations
Spinal cord
  • Spinal Cord Injury
Spinal stenosis
  • Cervical
  • Lumbar
  • Lumbosacral
Tumors
  • Metastatic tumors
  • Primary benign tumors
  • Primary malign tumors

APPLICATION LETTER EXAMPLE:

Editor-in-Chief
The Journal of Turkish Spinal Surgery

Dear Editor,

We enclose the manuscript titled ‘…..’ for consideration to publish in The Journal of Turkish Spinal Surgery.

The following authors have designed the study (AU: Parent¬hetically insert names of the appropriate authors), gathered the data (AU: Parenthetically insert names of the appropriate authors), analyzed the data (AU: Parenthetically insert names of the appropriate authors), wrote the initial drafts (AU: Pa¬renthetically insert initials of the appropriate authors), and ensure the accuracy of the data and analysis (AU: Parentheti¬cally insert names of the appropriate authors).

I confirm that all authors have seen and agree with the con¬tents of the manuscript and agree that the work has not been submitted or published elsewhere in whole or in part.

As the Corresponding Author, I (and any other authors) understand that The Journal of Turkish Spinal Surgery re¬quires all authors to specify any contracts or agreements they might have signed with commercial third parties sup¬porting any portion of the work. I further understand such information will be held in confidence while the paper is under review and will not influence the editorial decision, but that if the article is accepted for publication, a disclo¬sure statement will appear with the article. I have selected the following statement(s) to reflect the relationships of myself and any other author with a commercial third party related to the study:

1) All authors certify that they not have signed any agre¬ement with a commercial third party related to this study which would in any way limit publication of any and all data generated for the study or to delay publication for any reason.

2) One or more of the authors (initials) certifies that he or she has signed agreements with a commercial third party related to this study and that those agreements allow commercial third party to own or control the data gene¬rated by this study and review and modify any manuscript but not prevent or delay publication.

3) One or more of the authors (AU: Parenthetically insert initials of the appropriate authors) certifies that he or she has signed agreements with a commercial third party re¬lated to this study and that those agreements allow com¬mercial third party to own or control the data and to revi¬ew and modify any manuscript and to control timing but not prevent publication.
Sincerely,

Date:
Corresponding Author:
Address:
Phone:
Fax-mail:
GSM:
E-mail:

AUTHORSHIP RESPONSIBILITY, FINANCIAL DISCLOSURE, AND COPYRIGHT TRANSFER

MANUSCRIPT TITLE :

CORRESPONDING AUTHOR :

MAILING ADDRESS :

TELEPHONE / FAX NUMBERS :

Each author must read and sign the following statements; if necessary, photocopy this document and distribute to coauthors for their original ink signatures. Completed forms should be sent to the Editorial Office.

CONDITIONS OF SUBMISSION

RETAINED RIGHTS:

Except for copyright, other proprietary rights related to the Work shall be retained by the authors. To reproduce any text, figures, tables, or illustrations from this Work in future works of their own, the authors must obtain written permission from The Journal of Turkish Spinal Surgery; such permission cannot be unreasonably withheld by The Journal of Turkish Spinal Surgery.

ORIGINALITY:

Each author warrants that his or her sub¬mission to the Work is original and that he or she has full power to enter into this agreement. Neither this Work nor a similar work has been published nor shall be submitted for publication elsewhere while under consideration by this Publication.

AUTHORSHIP RESPONSIBILITY:

Each author certifies that he or she has participated sufficiently in the intellectual content, the analysis of data, if applicable, and the writing of the Work to take public responsibility for it. Each has re¬viewed the final version of the Work, believes it represents valid work, and approves it for publication. Moreover, sho¬uld the editors of the Publication request the data upon which the work is based, they shall produce it.

DISCLAIMER:

Each author warrants that this Work conta¬ins no libelous or unlawful statements and does not inf¬ringe on the rights of others. If excerpts (text, figures, tab¬les, or illustrations) from copyrighted works are included, a written release will be secured by the authors prior to submission, and credit to the original publication will be properly acknowledged. Each author warrants that he or she has obtained, prior to submission, written permissions from patients whose names or photographs are submitted as part of the Work. Should The Journal of Turkish Spinal Surgery request copies of such written releases, authors shall provide them to The Journal of Turkish Spinal Surgery in a timely manner.

TRANSFER OF COPYRIGHT

AUTHORS’ OWN WORK:

In consideration of The Journal of Turkish Spinal Surgery ‘s publication of the Work, the authors hereby transfer, assign, and otherwise convey all copyright ownership worldwide, in all languages, and in all forms of media now or hereafter known, including electro¬nic media such as CD-ROM, Internet, and Intranet, to The Journal of Turkish Spinal Surgery.

If The Journal of Turkish Spinal Surgery should decide for any reason not to publish an author’s submission to the Work, The Journal of Turkish Spinal Surgery shall give prompt notice of its decision to the corresponding author, this agreement shall terminate, and neither the author nor The Journal of Turkish Spinal Surgery shall be under any further liability or obligation.

The authors grant The Journal of Turkish Spinal Surgery the rights to use their names and biographical data (inc¬luding professional affiliation) in the Work and in its or the Publication’s promotion.


WORK MADE FOR HIRE:

If this work has been commissi¬oned by another person or organization, or if it has been written as part of the duties of an employee, an authorized representative of the commissioning organization or emp¬loyer must also sign this form stating his or her title in the organization.


FINANCIAL DISCLOSURE:

Each author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrange¬ments, etc.) that might pose a conflict of interest in con¬nection with the submitted article, except as disclosed on a separate attachment. All funding sources supporting the Work and all institutional or corporate affiliations of the authors are acknowledged in a footnote in the Work.

INSTITUTIONAL REVIEW BOARD/ANIMAL CARE COMMITTEE

APPROVAL:

Each author certifies that his or her institution has approved the protocol for any investigation involving humans or animals and that all experimentation was conducted in conformity with ethical and humane principles of research.

Signature Printed Name Date

Signature Printed Name Date

Signature Printed Name Date